Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 200 entries
Sorted by: Best Match Show Resources per page
Post-dural Puncture Headache: A Comparison Between Median and Paramedian Approaches in Orthopedic Patients.

Anesthesiology and pain medicine

Mosaffa F, Karimi K, Madadi F, Khoshnevis SH, Daftari Besheli L, Eajazi A.
PMID: 25729658
Anesth Pain Med. 2011;1(2):66-9. doi: 10.5812/kowsar.22287523.2159. Epub 2011 Sep 26.

BACKGROUND: Post-dural puncture headache (PDPH) is an iatrogenic complication of spinal anesthesia. Reported risk factors for PDPH include sex, age, pregnancy, needle tip shape and size, bevel orientation, approach and others. Little is known regarding the effect of different...

Cite
Mosaffa F, Karimi K, Madadi F, et al. Post-dural Puncture Headache: A Comparison Between Median and Paramedian Approaches in Orthopedic Patients. Anesth Pain Med. 2011;1(2):66-9doi: 10.5812/kowsar.22287523.2159.
Mosaffa, F., Karimi, K., Madadi, F., Khoshnevis, S. H., Daftari Besheli, L., & Eajazi, A. (2011). Post-dural Puncture Headache: A Comparison Between Median and Paramedian Approaches in Orthopedic Patients. Anesthesiology and pain medicine, 1(2), 66-9. https://doi.org/10.5812/kowsar.22287523.2159
Mosaffa, Faramarz, et al. "Post-dural Puncture Headache: A Comparison Between Median and Paramedian Approaches in Orthopedic Patients." Anesthesiology and pain medicine vol. 1,2 (2011): 66-9. doi: https://doi.org/10.5812/kowsar.22287523.2159
Mosaffa F, Karimi K, Madadi F, Khoshnevis SH, Daftari Besheli L, Eajazi A. Post-dural Puncture Headache: A Comparison Between Median and Paramedian Approaches in Orthopedic Patients. Anesth Pain Med. 2011;1(2):66-9. doi: 10.5812/kowsar.22287523.2159. Epub 2011 Sep 26. PMID: 25729658; PMCID: PMC4335747.
Copy Download .nbib Format: NLM
Cellobiohydrolase B of .

PeerJ

Woon JS, Mackeen MM, Illias RM, Mahadi NM, Broughton WJ, Murad AMA, Abu Bakar FD.
PMID: 29038760
PeerJ. 2017 Oct 12;5:e3909. doi: 10.7717/peerj.3909. eCollection 2017.

METHODS: In this study, the gene encoding a cellobiohydrolase B (RESULTS: Recombinant CBHB was over-expressed as a hyperglycosylated protein attached to DISCUSSION: Since CBHB alone was inactive against crystalline cellulose, these data suggested that it might work synergistically with...

Cite
Woon JS, Mackeen MM, Illias RM, et al. Cellobiohydrolase B of . PeerJ. 2017;5:e3909doi: 10.7717/peerj.3909.
Woon, J. S., Mackeen, M. M., Illias, R. M., Mahadi, N. M., Broughton, W. J., Murad, A. M. A., & Abu Bakar, F. D. (2017). Cellobiohydrolase B of . PeerJ, 5e3909. https://doi.org/10.7717/peerj.3909
Woon, James Sy-Keen, et al. "Cellobiohydrolase B of ." PeerJ vol. 5 (2017): e3909. doi: https://doi.org/10.7717/peerj.3909
Woon JS, Mackeen MM, Illias RM, Mahadi NM, Broughton WJ, Murad AMA, Abu Bakar FD. Cellobiohydrolase B of . PeerJ. 2017 Oct 12;5:e3909. doi: 10.7717/peerj.3909. eCollection 2017. PMID: 29038760; PMCID: PMC5641429.
Copy Download .nbib Format: NLM
Crystal structure of 4,5-bis-(3,4,5-tri-meth-oxy-phen-yl)-2H-1,2,3-triazole methanol monosolvate.

Acta crystallographica. Section E, Structure reports online

Madadi NR, Penthala NR, Bommagani S, Parkin S, Crooks PA.
PMID: 25484710
Acta Crystallogr Sect E Struct Rep Online. 2014 Sep 24;70:o1128-9. doi: 10.1107/S1600536814020911. eCollection 2014 Oct 01.

The title compound, C20H23N3O6·CH3OH, was synthesized by [3 + 2] cyclo-addition of (Z)-2,3-bis-(3,4,5-tri-meth-oxy-phen-yl)acrylo-nitrile with sodium azide and ammonium chloride in DMF/water. The central nitro-gen of the triazole ring is protonated. The dihedral angles between the triazole ring and the...

Cite
Madadi NR, Penthala NR, Bommagani S, et al. Crystal structure of 4,5-bis-(3,4,5-tri-meth-oxy-phen-yl)-2H-1,2,3-triazole methanol monosolvate. Acta Crystallogr Sect E Struct Rep Online. 2014;70:o1128-9doi: 10.1107/S1600536814020911.
Madadi, N. R., Penthala, N. R., Bommagani, S., Parkin, S., & Crooks, P. A. (2014). Crystal structure of 4,5-bis-(3,4,5-tri-meth-oxy-phen-yl)-2H-1,2,3-triazole methanol monosolvate. Acta crystallographica. Section E, Structure reports online, 70o1128-9. https://doi.org/10.1107/S1600536814020911
Madadi, Nikhil Reddy, et al. "Crystal structure of 4,5-bis-(3,4,5-tri-meth-oxy-phen-yl)-2H-1,2,3-triazole methanol monosolvate." Acta crystallographica. Section E, Structure reports online vol. 70 (2014): o1128-9. doi: https://doi.org/10.1107/S1600536814020911
Madadi NR, Penthala NR, Bommagani S, Parkin S, Crooks PA. Crystal structure of 4,5-bis-(3,4,5-tri-meth-oxy-phen-yl)-2H-1,2,3-triazole methanol monosolvate. Acta Crystallogr Sect E Struct Rep Online. 2014 Sep 24;70:o1128-9. doi: 10.1107/S1600536814020911. eCollection 2014 Oct 01. PMID: 25484710; PMCID: PMC4257191.
Copy Download .nbib Format: NLM
Synthesis and anti-cancer screening of novel heterocyclic-(2.

MedChemComm

Penthala NR, Madhukuri L, Thakkar S, Madadi NR, Lamture G, Eoff RL, Crooks PA.
PMID: 27066215
Medchemcomm. 2015 Aug 01;6(8):1535-1543. doi: 10.1039/C5MD00219B. Epub 2015 Jun 30.

No abstract available.

Cite
Penthala NR, Madhukuri L, Thakkar S, et al. Synthesis and anti-cancer screening of novel heterocyclic-(2. Medchemcomm. 2015;6(8):1535-1543doi: 10.1039/C5MD00219B.
Penthala, N. R., Madhukuri, L., Thakkar, S., Madadi, N. R., Lamture, G., Eoff, R. L., & Crooks, P. A. (2015). Synthesis and anti-cancer screening of novel heterocyclic-(2. MedChemComm, 6(8), 1535-1543. https://doi.org/10.1039/C5MD00219B
Penthala, Narsimha Reddy, et al. "Synthesis and anti-cancer screening of novel heterocyclic-(2." MedChemComm vol. 6,8 (2015): 1535-1543. doi: https://doi.org/10.1039/C5MD00219B
Penthala NR, Madhukuri L, Thakkar S, Madadi NR, Lamture G, Eoff RL, Crooks PA. Synthesis and anti-cancer screening of novel heterocyclic-(2. Medchemcomm. 2015 Aug 01;6(8):1535-1543. doi: 10.1039/C5MD00219B. Epub 2015 Jun 30. PMID: 27066215; PMCID: PMC4821443.
Copy Download .nbib Format: NLM
Percutaneous Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Implantation Is Safe for Reconstruction of Human Lower Limb Long Bone Atrophic Nonunion.

Cell journal

Emadedin M, Labibzadeh N, Fazeli R, Mohseni F, Hosseini SE, Moghadasali R, Mardpour S, Azimian V, Goodarzi A, Ghorbani Liastani M, Mirazimi Bafghi A, Baghaban Eslaminejad M, Aghdami N.
PMID: 28367426
Cell J. 2017 Apr-Jun;19(1):159-165. doi: 10.22074/cellj.2016.4866. Epub 2016 Dec 21.

OBJECTIVE: Nonunion is defined as a minimum of a 9-month period of time since an injury with no visibly progressive signs of healing for 3 months. Recent studies show that application of mesenchymal stromal cells (MSCs) in the laboratory...

Cite
Emadedin M, Labibzadeh N, Fazeli R, et al. Percutaneous Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Implantation Is Safe for Reconstruction of Human Lower Limb Long Bone Atrophic Nonunion. Cell J. 2016;19(1):159-165doi: 10.22074/cellj.2016.4866.
Emadedin, M., Labibzadeh, N., Fazeli, R., Mohseni, F., Hosseini, S. E., Moghadasali, R., Mardpour, S., Azimian, V., Goodarzi, A., Ghorbani Liastani, M., Mirazimi Bafghi, A., Baghaban Eslaminejad, M., & Aghdami, N. (2017). Percutaneous Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Implantation Is Safe for Reconstruction of Human Lower Limb Long Bone Atrophic Nonunion. Cell journal, 19(1), 159-165. https://doi.org/10.22074/cellj.2016.4866
Emadedin, Mohsen, et al. "Percutaneous Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Implantation Is Safe for Reconstruction of Human Lower Limb Long Bone Atrophic Nonunion." Cell journal vol. 19,1 (2017): 159-165. doi: https://doi.org/10.22074/cellj.2016.4866
Emadedin M, Labibzadeh N, Fazeli R, Mohseni F, Hosseini SE, Moghadasali R, Mardpour S, Azimian V, Goodarzi A, Ghorbani Liastani M, Mirazimi Bafghi A, Baghaban Eslaminejad M, Aghdami N. Percutaneous Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Implantation Is Safe for Reconstruction of Human Lower Limb Long Bone Atrophic Nonunion. Cell J. 2017 Apr-Jun;19(1):159-165. doi: 10.22074/cellj.2016.4866. Epub 2016 Dec 21. PMID: 28367426; PMCID: PMC5241512.
Copy Download .nbib Format: NLM
The Effects of Prolotherapy With Hypertonic Dextrose Versus Prolozone (Intraarticular Ozone) in Patients With Knee Osteoarthritis.

Anesthesiology and pain medicine

Hashemi M, Jalili P, Mennati S, Koosha A, Rohanifar R, Madadi F, Razavi SS, Taheri F.
PMID: 26587401
Anesth Pain Med. 2015 Oct 17;5(5):e27585. doi: 10.5812/aapm.27585. eCollection 2015 Oct.

BACKGROUND: Knee osteoarthritis (KOA) is a common disabling disease. Limited studies have demonstrated that prolotherapy with dextrose or with prolozone can be helpful in the treatment of patients with KOA.OBJECTIVES: In the current study, we compared the results between...

Cite
Hashemi M, Jalili P, Mennati S, et al. The Effects of Prolotherapy With Hypertonic Dextrose Versus Prolozone (Intraarticular Ozone) in Patients With Knee Osteoarthritis. Anesth Pain Med. 2015;5(5):e27585doi: 10.5812/aapm.27585.
Hashemi, M., Jalili, P., Mennati, S., Koosha, A., Rohanifar, R., Madadi, F., Razavi, S. S., & Taheri, F. (2015). The Effects of Prolotherapy With Hypertonic Dextrose Versus Prolozone (Intraarticular Ozone) in Patients With Knee Osteoarthritis. Anesthesiology and pain medicine, 5(5), e27585. https://doi.org/10.5812/aapm.27585
Hashemi, Masoud, et al. "The Effects of Prolotherapy With Hypertonic Dextrose Versus Prolozone (Intraarticular Ozone) in Patients With Knee Osteoarthritis." Anesthesiology and pain medicine vol. 5,5 (2015): e27585. doi: https://doi.org/10.5812/aapm.27585
Hashemi M, Jalili P, Mennati S, Koosha A, Rohanifar R, Madadi F, Razavi SS, Taheri F. The Effects of Prolotherapy With Hypertonic Dextrose Versus Prolozone (Intraarticular Ozone) in Patients With Knee Osteoarthritis. Anesth Pain Med. 2015 Oct 17;5(5):e27585. doi: 10.5812/aapm.27585. eCollection 2015 Oct. PMID: 26587401; PMCID: PMC4644302.
Copy Download .nbib Format: NLM
Diffusive transport of light in a Kelvin foam.

Physical review. E, Statistical, nonlinear, and soft matter physics

Miri M, Madadi E, Stark H.
PMID: 16241415
Phys Rev E Stat Nonlin Soft Matter Phys. 2005 Sep;72(3):031111. doi: 10.1103/PhysRevE.72.031111. Epub 2005 Sep 28.

Although diffusing-wave spectroscopy has already been successfully applied to study dynamic properties of foams, we still lack a clear understanding of the diffusive transport of photons in foams. In this paper, we present a thorough study of photon diffusion...

Cite
Miri M, Madadi E, Stark H. Diffusive transport of light in a Kelvin foam. Phys Rev E Stat Nonlin Soft Matter Phys. 2005;72(3):031111doi: 10.1103/PhysRevE.72.031111.
Miri, M., Madadi, E., & Stark, H. (2005). Diffusive transport of light in a Kelvin foam. Physical review. E, Statistical, nonlinear, and soft matter physics, 72(3), 031111. https://doi.org/10.1103/PhysRevE.72.031111
Miri, MirFaez, et al. "Diffusive transport of light in a Kelvin foam." Physical review. E, Statistical, nonlinear, and soft matter physics vol. 72,3 (2005): 031111. doi: https://doi.org/10.1103/PhysRevE.72.031111
Miri M, Madadi E, Stark H. Diffusive transport of light in a Kelvin foam. Phys Rev E Stat Nonlin Soft Matter Phys. 2005 Sep;72(3):031111. doi: 10.1103/PhysRevE.72.031111. Epub 2005 Sep 28. PMID: 16241415.
Copy Download .nbib Format: NLM
L-Proline catalyzed one-step synthesis of 4,5-diaryl-2.

Tetrahedron letters

Penthala NR, Madadi NR, Janganati V, Crooks PA.
PMID: 25267862
Tetrahedron Lett. 2014 Oct 01;55(40):5562-5565. doi: 10.1016/j.tetlet.2014.08.027.

Use of a novel reagent has been established for the synthesis of a series of 4,5-diaryl-2

Cite
Penthala NR, Madadi NR, Janganati V, et al. L-Proline catalyzed one-step synthesis of 4,5-diaryl-2. Tetrahedron Lett. 2014;55(40):5562-5565doi: 10.1016/j.tetlet.2014.08.027.
Penthala, N. R., Madadi, N. R., Janganati, V., & Crooks, P. A. (2014). L-Proline catalyzed one-step synthesis of 4,5-diaryl-2. Tetrahedron letters, 55(40), 5562-5565. https://doi.org/10.1016/j.tetlet.2014.08.027
Penthala, Narsimha Reddy, et al. "L-Proline catalyzed one-step synthesis of 4,5-diaryl-2." Tetrahedron letters vol. 55,40 (2014): 5562-5565. doi: https://doi.org/10.1016/j.tetlet.2014.08.027
Penthala NR, Madadi NR, Janganati V, Crooks PA. L-Proline catalyzed one-step synthesis of 4,5-diaryl-2. Tetrahedron Lett. 2014 Oct 01;55(40):5562-5565. doi: 10.1016/j.tetlet.2014.08.027. PMID: 25267862; PMCID: PMC4175744.
Copy Download .nbib Format: NLM
Unusually High Levels of CA19-9 Associated with Mature Cystic Teratoma of the Ovary.

Case reports in obstetrics and gynecology

Madaan M, Puri M, Sharma R, Kaur H, Trivedi SS.
PMID: 25276448
Case Rep Obstet Gynecol. 2014;2014:187910. doi: 10.1155/2014/187910. Epub 2014 Sep 08.

Introduction. Mature cystic teratoma is the benign tumor of the ovary. CA19-9 levels, although a marker of pancreatic malignancy, have been found to be raised in large ovarian mature cystic teratomas. Case Report. We report a case of a...

Cite
Madaan M, Puri M, Sharma R, et al. Unusually High Levels of CA19-9 Associated with Mature Cystic Teratoma of the Ovary. Case Rep Obstet Gynecol. 2014;2014:187910doi: 10.1155/2014/187910.
Madaan, M., Puri, M., Sharma, R., Kaur, H., & Trivedi, S. S. (2014). Unusually High Levels of CA19-9 Associated with Mature Cystic Teratoma of the Ovary. Case reports in obstetrics and gynecology, 2014187910. https://doi.org/10.1155/2014/187910
Madaan, Monika, et al. "Unusually High Levels of CA19-9 Associated with Mature Cystic Teratoma of the Ovary." Case reports in obstetrics and gynecology vol. 2014 (2014): 187910. doi: https://doi.org/10.1155/2014/187910
Madaan M, Puri M, Sharma R, Kaur H, Trivedi SS. Unusually High Levels of CA19-9 Associated with Mature Cystic Teratoma of the Ovary. Case Rep Obstet Gynecol. 2014;2014:187910. doi: 10.1155/2014/187910. Epub 2014 Sep 08. PMID: 25276448; PMCID: PMC4170748.
Copy Download .nbib Format: NLM
Data for proteome analysis of .

Data in brief

Ling HL, Rahmat Z, Murad AMA, Mahadi NM, Illias RM.
PMID: 28761915
Data Brief. 2017 Jul 14;14:35-40. doi: 10.1016/j.dib.2017.07.026. eCollection 2017 Oct.

No abstract available.

Cite
Ling HL, Rahmat Z, Murad AMA, et al. Data for proteome analysis of . Data Brief. 2017;14:35-40doi: 10.1016/j.dib.2017.07.026.
Ling, H. L., Rahmat, Z., Murad, A. M. A., Mahadi, N. M., & Illias, R. M. (2017). Data for proteome analysis of . Data in brief, 1435-40. https://doi.org/10.1016/j.dib.2017.07.026
Ling, How Lie, et al. "Data for proteome analysis of ." Data in brief vol. 14 (2017): 35-40. doi: https://doi.org/10.1016/j.dib.2017.07.026
Ling HL, Rahmat Z, Murad AMA, Mahadi NM, Illias RM. Data for proteome analysis of . Data Brief. 2017 Jul 14;14:35-40. doi: 10.1016/j.dib.2017.07.026. eCollection 2017 Oct. PMID: 28761915; PMCID: PMC5524313.
Copy Download .nbib Format: NLM
Molecular Characterization of Vancomycin, Mupirocin and Antiseptic Resistant .

Mediterranean journal of hematology and infectious diseases

Hadadi M, Heidari H, Ebrahim-Saraie HS, Motamedifar M.
PMID: 30210746
Mediterr J Hematol Infect Dis. 2018 Sep 01;10(1):e2018053. doi: 10.4084/MJHID.2018.053. eCollection 2018.

MATERIALS AND METHODS: This cross-sectional study was performed on a total of 120 MRSA isolates collected from two major hospitals in Shiraz, Iran. Minimum inhibitory concentrations (MICs) of vancomycin and mupirocin were determined by E-test method according to CLSI...

Cite
Hadadi M, Heidari H, Ebrahim-Saraie HS, et al. Molecular Characterization of Vancomycin, Mupirocin and Antiseptic Resistant . Mediterr J Hematol Infect Dis. 2018;10(1):e2018053doi: 10.4084/MJHID.2018.053.
Hadadi, M., Heidari, H., Ebrahim-Saraie, H. S., & Motamedifar, M. (2018). Molecular Characterization of Vancomycin, Mupirocin and Antiseptic Resistant . Mediterranean journal of hematology and infectious diseases, 10(1), e2018053. https://doi.org/10.4084/MJHID.2018.053
Hadadi, Mahtab, et al. "Molecular Characterization of Vancomycin, Mupirocin and Antiseptic Resistant ." Mediterranean journal of hematology and infectious diseases vol. 10,1 (2018): e2018053. doi: https://doi.org/10.4084/MJHID.2018.053
Hadadi M, Heidari H, Ebrahim-Saraie HS, Motamedifar M. Molecular Characterization of Vancomycin, Mupirocin and Antiseptic Resistant . Mediterr J Hematol Infect Dis. 2018 Sep 01;10(1):e2018053. doi: 10.4084/MJHID.2018.053. eCollection 2018. PMID: 30210746; PMCID: PMC6131108.
Copy Download .nbib Format: NLM
Retraction notice to Inhibition of proliferation and induction of apoptosis by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide in adult T-cell leukemia cells.

Chemico-biological interactions

Harakeh S, Diab-Assef M, El-Sabban M, Haddadin M, Gali-Muhtasib H.
PMID: 29273235
Chem Biol Interact. 2018 Jan 05;279:243. doi: 10.1016/j.cbi.2017.11.015.

No abstract available.

Cite
Harakeh S, Diab-Assef M, El-Sabban M, et al. Retraction notice to Inhibition of proliferation and induction of apoptosis by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide in adult T-cell leukemia cells. Chem Biol Interact. 2018;279:243doi: 10.1016/j.cbi.2017.11.015.
Harakeh, S., Diab-Assef, M., El-Sabban, M., Haddadin, M., & Gali-Muhtasib, H. (2018). Retraction notice to Inhibition of proliferation and induction of apoptosis by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide in adult T-cell leukemia cells. Chemico-biological interactions, 279243. https://doi.org/10.1016/j.cbi.2017.11.015
Harakeh, Steve, et al. "Retraction notice to Inhibition of proliferation and induction of apoptosis by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide in adult T-cell leukemia cells." Chemico-biological interactions vol. 279 (2018): 243. doi: https://doi.org/10.1016/j.cbi.2017.11.015
Harakeh S, Diab-Assef M, El-Sabban M, Haddadin M, Gali-Muhtasib H. Retraction notice to Inhibition of proliferation and induction of apoptosis by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide in adult T-cell leukemia cells. Chem Biol Interact. 2018 Jan 05;279:243. doi: 10.1016/j.cbi.2017.11.015. PMID: 29273235.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 200 entries